SCHEMBL622902

SCHEMBL622902

Cc1cc(Oc2cnc(NC(=O)C(OC3Cc4ccccc4C3)c3ccc(S(=O)(=O)C4CC4)cc3)s2)ccc1C(=O)O

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623679 0.94 GCK (0.71) GCK
SCHEMBL185077 0.90 GCK (1.00) GCK
SCHEMBL11971916 0.88 GCK (1.00) GCK
SCHEMBL624963 0.87 GCK (0.62) GCK
SCHEMBL11971714 0.84 GCK (1.00) GCK
SCHEMBL625624 0.84 GCK (0.85) GCK
SCHEMBL184942 0.83 GCK (0.88) GCK
SCHEMBL623522 0.83 GCK (0.65) GCK
SCHEMBL11972269 0.83 GCK (1.00) GCK
SCHEMBL11972265 0.81 GCK (1.00) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO claimed